H1 FY26 Trading Update
H1 FY26 revenue £74.5m, up 57%, ahead of expectations; FY26 guidance raised to £140m.
vs expectations: ahead
- H1 FY26 Revenue £74.5m (prior £47.6m)
- H1 FY26 Revenue growth 57%
- FY26 Revenue guidance approximately £140m
- FY26 Consensus Revenue £133.5m
- FY26 Consensus Adjusted EBITDA £37.7m
Select text to share a quote on X · sign in to keep highlights & notes in your APN notes
Applied Nutrition plc, a leading sports nutrition, health and wellness brand, today announces an update on trading for the six months ended 31 January 2026 ("H1 FY26").
H1 FY261 Trading Update
The Group delivered a very strong performance in the first half of the financial year, generating revenue of £74.5 million, an increase of 57% on H1 FY25 (£47.6 million). EBITDA for the period was also ahead of management expectations.
As noted in the December Trading Update, the Group entered the January peak Health, Fitness & Wellbeing period with retail orders and resultant customer stock levels, significantly above expectations. This is a consequence of the success of its channel diversification across UK high street health retailers, grocers and discounters. Together with accelerated demand for a number of H1 FY26 product launches, this is expected to result in a more H1‑weighted revenue profile than in prior years.
FY26 Outlook2
Reflecting the strong first‑half performance, the Group now anticipates that FY26 results will be ahead of updated market consensus expectations3. Management currently expects full‑year revenue of approximately £140 million.
Notice of Results
The Group will announce its Interim Results for the six months ended 31 January 2026 on 23 March 2026.
Analyst Presentation
Thomas Ryder, CEO, Steven Granite, COO and Joe Pollard, CFO, will host a virtual presentation and Q&A session for analysts at 09.00 GMT on 23 March 2026.
To register, please email appliednutrition@almastrategic.com
Retail Investor Presentation
Management will also host a virtual presentation and Q&A session for retail investors at 16.00 GMT on 23 March 2026.
To register to attend, please use the following link: https://engageinvestor.news/APN_IP_0326
Notes:
1 All figures used in this announcement relating to FY26 remain subject to audit.
2 Please see cautionary note regarding forward-looking statements below.
3 Consensus market expectations for FY26 as calculated by the Company immediately before this announcement are:
| Measure | FY26 |
| Revenue | £133.5 million |
| Adjusted EBITDA | £37.7 million |
The Company periodically updates these calculations and publishes them at: https://www.appliednutritionplc.com/consensus-earnings-estimates
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.